Purchase Short-Term Access

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
Jonas Oldgren, MD, PhD; Marco Alings, MD, PhD; Harald Darius, MD, PhD; Hans-Christoph Diener, MD, PhD; John Eikelboom, MD; Michael D. Ezekowitz, MD, PhD; Gabriel Kamensky, MD, PhD; Paul A. Reilly, PhD; Sean Yang, MSc; Salim Yusuf, MBBS, DPhil; Lars Wallentin, MD, PhD; Stuart J. Connolly, MD; on behalf of the RE-LY Investigators
Annals of Internal Medicine 2011;155:660-667. doi:10.7326/0003-4819-155-10-201111150-00004

Purchase Online access to this article for 24 hours
Buy Now for $32.00
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.